(Q79117983)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14526396%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14526396%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

17 March 2024

5

Jay Lefkowitch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14526396%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

8

Jean C Emond

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14526396%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Dianne LaPointe Rudow

4

object named as

Dianne Lapointe-Rudow

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14526396%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

author name string

Srikar Malireddy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14526396%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Milan Kinkhabwala

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14526396%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Paul J. Gaglio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14526396

17 March 2024

Brian S. Levitt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14526396

17 March 2024

Dianne Lapointe-Rudow

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14526396

17 March 2024

Jay Lefkowitch

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14526396

17 March 2024

Mark W. Russo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14526396

17 March 2024

Jean C. Emond

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14526396

17 March 2024

Robert S. Brown

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14526396

17 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14526396

17 March 2024

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14526396%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 December 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1053%2Fjlts.2003.50211

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

https://onlinelibrary.wiley.com/doi/full/10.1053/jlts.2003.50211

17 March 2024

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

17 March 2024

published in

Liver Transplantation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14526396%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14526396%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14526396%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

1028-1035

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14526396%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis C and liver transplantation

19 December 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.

17 March 2024

2

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients

17 March 2024

3

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

17 March 2024

4

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury

17 March 2024

5

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft

17 March 2024

6

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

The association between hepatitis C infection and survival after orthotopic liver transplantation

17 March 2024

7

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation

17 March 2024

8

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

Comparison of pharmacokinetics of Neoral and Sandimmune in stable pediatric liver transplant recipients

17 March 2024

9

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

Long-term outcome of hepatitis C infection after liver transplantation

17 March 2024

10

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation

17 March 2024

11

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

Predictors of patient and graft survival following liver transplantation for hepatitis C.

17 March 2024

12

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection

17 March 2024

13

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection

17 March 2024

14

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation

17 March 2024

15

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

Cell cycle regulation of hepatitis C virus internal ribosomal entry site-directed translation

17 March 2024

16

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels

17 March 2024

17

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury.

17 March 2024

18

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

Real-time monitoring of acute liver-allograft rejection using the Banff schema

17 March 2024

19

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

Impact of immunosuppressive therapy on recurrence of hepatitis C.

17 March 2024

20

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

Outflow reconstruction in right hepatic live donor liver transplantation

17 March 2024

21

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

Pathogenesis of hepatitis C virus recurrence in the liver allograft

17 March 2024

22

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

Are posttransplantation protocol liver biopsies useful in the long term?

17 March 2024

23

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation

17 March 2024

24

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: lessons on tolerability and efficacy.

17 March 2024

25

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin

17 March 2024

26

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C.

17 March 2024

27

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

Hepatitis C infection in patients undergoing liver retransplantation

17 March 2024

28

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

Long-term outcome of hepatitis C infection after liver transplantation

17 March 2024

30

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50211

17 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14526396%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference